Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 2

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Dermatologic 9Sarcoma 2

Conditions

Dermatofibrosarcoma 2Skin Neoplasms 1Neoplasms, Adnexal and Skin Appendage 1Melanoma 1Histiocytoma, Malignant Fibrous 1Carcinoma, Squamous Cell 1Carcinoma, Basal Cell 1

Interventions

Radiotherapy 221Cyclophosphamide 211Doxorubicin 210Temozolomide 182Ifosfamide 121Filgrastim 111Imatinib Mesylate 104Etoposide 101Vincristine 92Gemcitabine 89Bevacizumab 83Magnetic Resonance Spectroscopy 81Irinotecan 79pembrolizumab 75Radiation 70Carboplatin 65Methotrexate 62pazopanib 61Nivolumab 58Cisplatin 58fludarabine phosphate 57Surgical Procedures, Operative 57Peripheral Blood Stem Cell Transplantation 57Specimen Handling 56Trabectedin 52Docetaxel 50Biopsy 50Busulfan 49Melphalan 46Paclitaxel 44

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Mohs Surgery × Sarcoma × Clear all
NCT03381846 2020-08-05

Treatment of Dermatofibrosarcoma Protuberans in Patients 10 Years and Younger

Mayo Clinic

Phase NA Completed
7 enrolled
Sarcoma

Dermatofibrosarcoma

NCT02310503 2020-05-05

REGESMOHS

Fundación Academia Española de Dermatología

Completed
6,000 enrolled
DermatologicSarcoma

Carcinoma, Basal Cell, Carcinoma, Squamous Cell, Melanoma, Skin Neoplasms, Dermatofibrosarcoma, Neoplasms, Adnexal and Skin Appendage, Histiocytoma, Malignant Fibrous

Data powered by HemOnc (CC BY 4.0) Colophon ⚡